2021
DOI: 10.1212/nxi.0000000000001085
|View full text |Cite
|
Sign up to set email alerts
|

Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis

Abstract: Background and ObjectivesTo investigate the genetic determinants of the most common type of antibody-mediated autoimmune encephalitis, anti-NMDA receptor (anti-NMDAR) encephalitis.MethodsWe performed a genome-wide association study in 178 patients with anti-NMDAR encephalitis and 590 healthy controls, followed by a colocalization analysis to identify putatively causal genes.ResultsWe identified 2 independent risk loci harboring genome-wide significant variants (p < 5 × 10−8, OR ≥ 2.2), 1 on chromosome 15, h… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 31 publications
0
11
0
Order By: Relevance
“…A family history of autoimmune disease is more common in patients with paraneoplastic syndromes 11 . An underlying immunogenetic predisposition to paraneoplastic neurologic disorders may be present, as seen with human leukocyte antigen–type and immune gene associations for NMDA-receptor encephalitis 12 . This is most suggestive in syndromes with a low incidence of associated tumors: 90% of patients with IgLON family member 5 (IgLON5)-related syndromes have the DQB1*05 allele and 60% also have the DRB1*10:01 allele; 90% of patients with contactin-associated proteinlike 2 (CASPR2)-related syndromes have the DRB1*11:01 allele; and 40% of patients with glutamic acid decarboxylase 65 (GAD65)-related syndromes have the DQB*02:01 allele.…”
Section: Clinical Evaluation Of Paraneoplastic Disordersmentioning
confidence: 99%
“…A family history of autoimmune disease is more common in patients with paraneoplastic syndromes 11 . An underlying immunogenetic predisposition to paraneoplastic neurologic disorders may be present, as seen with human leukocyte antigen–type and immune gene associations for NMDA-receptor encephalitis 12 . This is most suggestive in syndromes with a low incidence of associated tumors: 90% of patients with IgLON family member 5 (IgLON5)-related syndromes have the DQB1*05 allele and 60% also have the DRB1*10:01 allele; 90% of patients with contactin-associated proteinlike 2 (CASPR2)-related syndromes have the DRB1*11:01 allele; and 40% of patients with glutamic acid decarboxylase 65 (GAD65)-related syndromes have the DQB*02:01 allele.…”
Section: Clinical Evaluation Of Paraneoplastic Disordersmentioning
confidence: 99%
“…In addition, by studying the colocalization signals in different brain regions and immune cells expressing quantitative characteristic loci, Tietz et al found that DDB2 may be the pathogenic gene that causes anti-NMDAR receptor (antiNMDAR) encephalitis [ 103 ].…”
Section: Novel Discovery: Role Of Ddb2 In Other Diseasesmentioning
confidence: 99%
“…Later, very weak and doubtful associations were reported with B*07:02 in adult patients of Caucasian origin [ 96 ] and with DRB1*16:02 in a Chinese cohort [ 97 ]. However, these associations have not been confirmed in a very recent genome-wide association study (GWAS) including the largest cohort ( n = 178) investigated to date [ 98 ].…”
Section: Molecular Biomarkers In Anti-nmdar Encephalitismentioning
confidence: 99%
“…Nevertheless, the first GWAS performed in anti-NMDAR encephalitis obtained no positive results, although the number of patients included was fairly small [ 96 ]. The same authors have very recently doubled the sample size and reported a significant association with LRRK1 (leucine-rich repeat kinase 1), ACP2 (lysosomal acid phosphatase), and NR1H3 (nuclear receptor subfamily 1 group H member 3) genes, which might have some yet poorly defined functions in immune and inflammatory responses [ 98 ]. Despite being appealing, these results have to be carefully considered, since there was no replication cohort due to the still insufficient sample size [ 98 ].…”
Section: Molecular Biomarkers In Anti-nmdar Encephalitismentioning
confidence: 99%